Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Merck & Co., Inc.MRK · Entity 2807 | EVP,Chief Info&Digital Officer | October 30, 2019 | November 01, 2019 |
| STANLEY BLACK & DECKER, INC.SWK · Entity 3378 | Director | March 17, 2020 | March 19, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Merck & Co., Inc.
Report date October 30, 2019 · Filed November 01, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 7,142 |
Ending reported balance
After 2019-10-30 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2019-10-30 · Exercise / conversion · Acquired 11,436 · Balance 11,436 Row 2 · 2019-10-30 · Tax withholding · Disposed 4,294 · Balance 7,142 |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Expires 2021-10-30 | Direct | 22,872 |
Reported balance
After 2019-10-30 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-10-30 · Exercise / conversion · Disposed 11,436 · Balance 22,872 F1: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F2: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F2: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021.
STANLEY BLACK & DECKER, INC.
Report date March 17, 2020 · Filed March 19, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred SharesSEC Table II · derivative / convertible security | Direct | 2,301.9802 |
Reported balance
After 2020-03-17 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-03-17 · Grant · Acquired 15.7959 · Balance 2,301.9802 F1: Fair market value on date established in Plan with respect to payment of fee or dividend F2: Currently 100% vested F3: The reporting director will receive 5 approximately equal annual installments of common stock of the corporation starting on the first business day immediately following the date on which he or she ceases to be a Director of the Corporation. |
Filing footnotes · ownership attribution and instrument terms
F1: Fair market value on date established in Plan with respect to payment of fee or dividend
F2: Currently 100% vested
F3: The reporting director will receive 5 approximately equal annual installments of common stock of the corporation starting on the first business day immediately following the date on which he or she ceases to be a Director of the Corporation.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 17, 2020 Filed Mar 19, 2020 21:03 UTC | STANLEY BLACK & DECKER, INC. SWK · Entity 3378 | GrantDeferred Shares · Derivative | 15.7959 | $84.92 | $1,341.31 |
DisclosureSEC source: 0001127602-20-011525 · form4.xml · derivative · entry 1 Scholefield James H · CIK 0001720922 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,301.9802 Underlying: Common Stock · 15.7959 shares Expires not disclosed F1 · derivative.exercise_price: Fair market value on date established in Plan with respect to payment of fee or dividend F2 · derivative.exercise_date: Currently 100% vested F3 · derivative.expiration_date: The reporting director will receive 5 approximately equal annual installments of common stock of the corporation starting on the first business day immediately following the date on which he or she ceases to be a Director of the Corporation. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 21:14 UTC | STANLEY BLACK & DECKER, INC. SWK · Entity 3378 | GrantDeferred Shares · Derivative | 342.2482 | $91.31 | $31,250.00 |
DisclosureSEC source: 0001127602-20-011289 · form4.xml · derivative · entry 1 Scholefield James H · CIK 0001720922 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,286.1843 Underlying: Common Stock · 342.2482 shares Expires not disclosed F1 · derivative.exercise_price: Fair market value on date established in Plan with respect to payment of fee or dividend F2 · derivative.exercise_date: Currently 100% vested F3 · derivative.expiration_date: The reporting director will receive 5 approximately equal annual installments of common stock of the corporation starting on the first business day immediately following the date on which he or she ceases to be a Director of the Corporation Read SEC document |
| December 17, 2019 Filed Dec 19, 2019 22:00 UTC | STANLEY BLACK & DECKER, INC. SWK · Entity 3378 | GrantDeferred Shares · Derivative | 7.3167 | $164.79 | $1,205.68 |
DisclosureSEC source: 0001127602-19-035527 · form4.xml · derivative · entry 1 Scholefield James H · CIK 0001720922 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,943.9361 Underlying: Common Stock · 7.3167 shares Expires not disclosed F1 · derivative.exercise_price: Fair market value on date established in Plan with respect to payment of fee or dividend F2 · derivative.exercise_date: Currently 100% vested F3 · derivative.expiration_date: The reporting director will receive common stock of the corporation on the first business day of the calendar year immediately following the year in which he or she ceases to be a director Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 21:58 UTC | STANLEY BLACK & DECKER, INC. SWK · Entity 3378 | GrantDeferred Shares · Derivative | 189.2506 | $165.13 | $31,250.01 |
DisclosureSEC source: 0001127602-19-035385 · form4.xml · derivative · entry 1 Scholefield James H · CIK 0001720922 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,936.6194 Underlying: Common Stock · 189.2506 shares Expires not disclosed F1 · derivative.exercise_price: Fair market value on date established in Plan with respect to payment of fee or dividend F2 · derivative.exercise_date: Currently 100% vested F3 · derivative.expiration_date: The reporting director will receive common stock of the corporation on the first business day of the calendar year immediately following the year in which he or she ceases to be a director Read SEC document |
| October 30, 2019 Filed Nov 1, 2019 21:04 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionRestricted Stock Unit · Derivative | 11,436 | $85.10 | $973,203.60 |
DisclosureSEC source: 0001225208-19-014013 · doc4.xml · derivative · entry 3 Scholefield James H · CIK 0001720922 · EVP,Chief Info&Digital Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,872 Underlying: Common Stock · 11,436 shares Expires 2021-10-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F2 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021. Read SEC document |
| October 30, 2019 Filed Nov 1, 2019 21:04 UTC | Merck & Co., Inc. MRK · Entity 2807 | Tax withholdingCommon Stock | 4,294 | $85.10 | $365,419.40 |
DisclosureSEC source: 0001225208-19-014013 · doc4.xml · nonDerivative · entry 2 Scholefield James H · CIK 0001720922 · EVP,Chief Info&Digital Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,142 Read SEC document |
| October 30, 2019 Filed Nov 1, 2019 21:04 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionCommon Stock | 11,436 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-014013 · doc4.xml · nonDerivative · entry 1 Scholefield James H · CIK 0001720922 · EVP,Chief Info&Digital Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,436 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 17, 2019 Filed Sep 19, 2019 21:12 UTC | STANLEY BLACK & DECKER, INC. SWK · Entity 3378 | GrantDeferred Shares · Derivative | 7.3423 | $143.20 | $1,051.38 |
DisclosureSEC source: 0001127602-19-028822 · form4.xml · derivative · entry 1 Scholefield James H · CIK 0001720922 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,747.3688 Underlying: Common Stock · 7.3423 shares Expires not disclosed F1 · derivative.exercise_price: Fair market value on date established in Plan with respect to payment of fee or dividend F2 · derivative.exercise_date: Currently 100% vested F3 · derivative.expiration_date: The reporting director will receive common stock of the corporation on the first business day of the calendar year immediately following the year in which he or she ceases to be a director Read SEC document |
| September 16, 2019 Filed Sep 18, 2019 20:09 UTC | STANLEY BLACK & DECKER, INC. SWK · Entity 3378 | GrantDeferred Shares · Derivative | 216.2779 | $144.49 | $31,249.99 |
DisclosureSEC source: 0001127602-19-028723 · form4.xml · derivative · entry 1 Scholefield James H · CIK 0001720922 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,740.0265 Underlying: Common Stock · 216.2779 shares Expires not disclosed F1 · derivative.exercise_price: Fair market value on date established in Plan with respect to payment of fee or dividend F2 · derivative.exercise_date: Currently 100% vested F3 · derivative.expiration_date: The reporting director will receive common stock of the corporation on the first business day of the calendar year immediately following the year in which he or she ceases to be a director Read SEC document |
| June 18, 2019 Filed Jun 19, 2019 21:29 UTC | STANLEY BLACK & DECKER, INC. SWK · Entity 3378 | GrantDeferred Shares · Derivative | 5.9607 | $143.55 | $855.66 |
DisclosureSEC source: 0001127602-19-022274 · form4.xml · derivative · entry 2 Scholefield James H · CIK 0001720922 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,523.7486 Underlying: Common Stock · 5.9607 shares Expires not disclosed F1 · derivative.exercise_price: Fair market value on date established in Plan with respect to payment of fee or dividend F2 · derivative.exercise_date: Currently 100% vested F3 · derivative.expiration_date: The reporting director will receive common stock of the corporation on the first business day of the calendar year immediately following the year in which he or she ceases to be a director Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 21:29 UTC | STANLEY BLACK & DECKER, INC. SWK · Entity 3378 | GrantDeferred Shares · Derivative | 221.3447 | $141.18 | $31,250.00 |
DisclosureSEC source: 0001127602-19-022274 · form4.xml · derivative · entry 1 Scholefield James H · CIK 0001720922 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,517.7879 Underlying: Common Stock · 221.3447 shares Expires not disclosed F1 · derivative.exercise_price: Fair market value on date established in Plan with respect to payment of fee or dividend F2 · derivative.exercise_date: Currently 100% vested F3 · derivative.expiration_date: The reporting director will receive common stock of the corporation on the first business day of the calendar year immediately following the year in which he or she ceases to be a director Read SEC document |
| May 03, 2019 Filed May 7, 2019 23:41 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 39,518 | $0.00 Strike: $80.00 | $0.00 |
DisclosureSEC source: 0001104659-19-027587 · a4.xml · derivative · entry 1 Scholefield James H · CIK 0001720922 · EVP,Chief Info&Digital Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,518 Underlying: Common Stock · 39,518 shares Expires 2029-05-02 F1 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022. Read SEC document |
| April 17, 2019 Filed Apr 18, 2019 20:30 UTC | STANLEY BLACK & DECKER, INC. SWK · Entity 3378 | GrantRestricted Stock Units · Derivative | 1,100 | $145.47 Strike: $0.00 | $160,017.00 |
DisclosureSEC source: 0001127602-19-015820 · form4.xml · derivative · entry 1 Scholefield James H · CIK 0001720922 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,993 Underlying: Common Stock · 1,100 shares Expires not disclosed F1 · derivative.exercise_date: Currently 100% vested F2 · derivative.expiration_date: The reporting director will receive a cash payment based on the market value of the Corporation's Common Stock in five approximately equal annual installments commencing at the time she ceases to be a member of the Board Read SEC document |
| March 19, 2019 Filed Mar 21, 2019 20:17 UTC | STANLEY BLACK & DECKER, INC. SWK · Entity 3378 | GrantDeferred Shares · Derivative | 5.1987 | $133.99 | $696.55 |
DisclosureSEC source: 0001127602-19-012665 · form4.xml · derivative · entry 1 Scholefield James H · CIK 0001720922 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,296.4432 Underlying: Common Stock · 5.1987 shares Expires not disclosed F1 · derivative.exercise_price: Fair market value on date established in Plan with respect to payment of fee or dividend F2 · derivative.exercise_date: Currently 100% vested F3 · derivative.expiration_date: The reporting director will receive common stock of the corporation on the first business day of the calendar year immediately following the year in which he or she ceases to be a director Read SEC document |
| March 15, 2019 Filed Mar 19, 2019 20:58 UTC | STANLEY BLACK & DECKER, INC. SWK · Entity 3378 | GrantDeferred Shares · Derivative | 235.8758 | $132.49 | $31,250.01 |
DisclosureSEC source: 0001127602-19-012266 · form4.xml · derivative · entry 1 Scholefield James H · CIK 0001720922 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,291.2445 Underlying: Common Stock · 235.8758 shares Expires not disclosed F1 · derivative.exercise_price: Fair market value on date established in Plan with respect to payment of fee or dividend F2 · derivative.exercise_date: Currently 100% vested F3 · derivative.expiration_date: The reporting director will receive common stock of the corporation on the first business day of the calendar year immediately following the year in which he or she ceases to be a director Read SEC document |
| December 18, 2018 Filed Dec 20, 2018 21:25 UTC | STANLEY BLACK & DECKER, INC. SWK · Entity 3378 | GrantDeferred Shares · Derivative | 4.3166 | $120.82 | $521.51 |
DisclosureSEC source: 0001127602-18-036968 · form4.xml · derivative · entry 1 Scholefield James H · CIK 0001720922 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,055.3687 Underlying: Common Stock · 4.3166 shares Expires not disclosed F1 · derivative.exercise_price: Fair market value on date established in Plan with respect to payment of fee or dividend F2 · derivative.exercise_date: Currently 100% vested F3 · derivative.expiration_date: The reporting director will receive common stock of the corporation on the first business day of the calendar year immediately following the year in which he or she ceases to be a director Read SEC document |
| December 17, 2018 Filed Dec 18, 2018 21:36 UTC | STANLEY BLACK & DECKER, INC. SWK · Entity 3378 | GrantDeferred Shares · Derivative | 260.9004 | $119.78 | $31,250.00 |
DisclosureSEC source: 0001127602-18-036589 · form4.xml · derivative · entry 1 Scholefield James H · CIK 0001720922 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,051.0521 Underlying: Common Stock · 260.9004 shares Expires not disclosed F1 · derivative.exercise_price: Fair market value on date established in Plan with respect to payment of fee or dividend F2 · derivative.exercise_date: Currently 100% vested F3 · derivative.expiration_date: The reporting director will receive common stock of the corporation on the first business day of the calendar year immediately following the year in which he or she ceases to be a director Read SEC document |
| October 30, 2018 Filed Nov 1, 2018 21:03 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 47,456 | $0.00 Strike: $72.87 | $0.00 |
DisclosureSEC source: 0001225208-18-015063 · doc4.xml · derivative · entry 2 Scholefield James H · CIK 0001720922 · EVP,Chief Info&Digital Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,456 Underlying: Common Stock · 47,456 shares Expires 2028-10-29 F3 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021. Read SEC document |
| October 30, 2018 Filed Nov 1, 2018 21:03 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantRestricted Stock Unit · Derivative | 34,308 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-015063 · doc4.xml · derivative · entry 1 Scholefield James H · CIK 0001720922 · EVP,Chief Info&Digital Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,308 Underlying: Common Stock · 34,308 shares Expires 2021-10-30 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F2 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021. Read SEC document |
| September 18, 2018 Filed Sep 20, 2018 20:20 UTC | STANLEY BLACK & DECKER, INC. SWK · Entity 3378 | GrantDeferred Shares · Derivative | 2.5487 | $149.55 | $381.16 |
DisclosureSEC source: 0001127602-18-028158 · form4.xml · derivative · entry 1 Scholefield James H · CIK 0001720922 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 790.1517 Underlying: Common Stock · 2.5487 shares Expires not disclosed F1 · derivative.exercise_price: Fair market value on date established in Plan with respect to payment of fee or dividend F2 · derivative.exercise_date: Currently 100% vested F3 · derivative.expiration_date: The reporting director will receive common stock of the corporation on the first business day of the calendar year immediately following the year in which he or she ceases to be a director Read SEC document |
| September 17, 2018 Filed Sep 19, 2018 20:14 UTC | STANLEY BLACK & DECKER, INC. SWK · Entity 3378 | GrantDeferred Shares · Derivative | 210.1052 | $148.74 | $31,250.00 |
DisclosureSEC source: 0001127602-18-028053 · form4.xml · derivative · entry 1 Scholefield James H · CIK 0001720922 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 787.603 Underlying: Common Stock · 210.1052 shares Expires not disclosed F1 · derivative.exercise_price: Fair market value on date established in Plan with respect to payment of fee or dividend F2 · derivative.exercise_date: Currently 100% vested F3 · derivative.expiration_date: The reporting director will receive common stock of the corporation on the first business day of the calendar year immediately following the year in which he or she ceases to be a director Read SEC document |
| June 19, 2018 Filed Jun 20, 2018 20:49 UTC | STANLEY BLACK & DECKER, INC. SWK · Entity 3378 | GrantDeferred Shares · Derivative | 1.6083 | $138.54 | $222.81 |
DisclosureSEC source: 0001127602-18-021612 · form4.xml · derivative · entry 1 Scholefield James H · CIK 0001720922 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 577.4978 Underlying: Common Stock · 1.6083 shares Expires not disclosed F1 · derivative.exercise_price: Fair market value on date established in Plan with respect to payment of fee or dividend F2 · derivative.exercise_date: Currently 100% vested F3 · derivative.expiration_date: The reporting director will receive common stock of the corporation on the first business day of the calendar year immediately following the year in which he or she ceases to be a director Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 19:40 UTC | STANLEY BLACK & DECKER, INC. SWK · Entity 3378 | GrantDeferred Shares · Derivative | 222.2222 | $140.63 | $31,250.00 |
DisclosureSEC source: 0001127602-18-021370 · form4.xml · derivative · entry 1 Scholefield James H · CIK 0001720922 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 575.8895 Underlying: Common Stock · 222.2222 shares Expires not disclosed F1 · derivative.exercise_price: Fair market value on date established in Plan with respect to payment of fee or dividend F2 · derivative.exercise_date: Currently 100% vested F3 · derivative.expiration_date: The reporting director will receive common stock of the corporation on the first business day of the calendar year immediately following the year in which he or she ceases to be a director Read SEC document |
| April 19, 2018 Filed Apr 23, 2018 20:26 UTC | STANLEY BLACK & DECKER, INC. SWK · Entity 3378 | GrantRestricted Stock Units · Derivative | 893 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-015100 · form4.xml · derivative · entry 1 Scholefield James H · CIK 0001720922 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 893 Underlying: Common Stock · 893 shares Expires not disclosed F1 · derivative.exercise_date: Currently 100% vested F2 · derivative.expiration_date: The reporting director will receive a cash payment based on the market value of the Corporation's Common Stock at the time he or she ceases to be a member of the Board Read SEC document |
| March 20, 2018 Filed Mar 22, 2018 20:26 UTC | STANLEY BLACK & DECKER, INC. SWK · Entity 3378 | GrantDeferred Shares · Derivative | 0.6152 | $158.19 | $97.32 |
DisclosureSEC source: 0001127602-18-012529 · form4.xml · derivative · entry 1 Scholefield James H · CIK 0001720922 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 353.6673 Underlying: Common Stock · 0.6152 shares Expires not disclosed F1 · derivative.exercise_price: Fair market value on date established in Plan with respect to payment of fee or dividend F2 · derivative.exercise_date: Currently 100% vested F3 · derivative.expiration_date: The reporting director will receive common stock of the corporation on the first business day of the calendar year immediately following the year in which he or she ceases to be a director Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 20:06 UTC | STANLEY BLACK & DECKER, INC. SWK · Entity 3378 | GrantDeferred Shares · Derivative | 198.5703 | $157.38 | $31,250.00 |
DisclosureSEC source: 0001127602-18-012033 · form4.xml · derivative · entry 1 Scholefield James H · CIK 0001720922 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 353.0521 Underlying: Common Stock · 198.5703 shares Expires not disclosed F1 · derivative.exercise_price: Fair market value on date established in Plan with respect to payment of fee or dividend F2 · derivative.exercise_date: Currently 100% vested F3 · derivative.expiration_date: The reporting director will receive common stock of the corporation on the first business day of the calendar year immediately following the year in which he or she ceases to be a director Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 21:54 UTC | STANLEY BLACK & DECKER, INC. SWK · Entity 3378 | GrantDeferred Shares · Derivative | 154.4818 | $166.27 | $25,684.93 |
DisclosureSEC source: 0001127602-17-035162 · form4.xml · derivative · entry 1 Scholefield James H · CIK 0001720922 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154.4818 Underlying: Common Stock · 154.4818 shares Expires not disclosed F1 · derivative.exercise_price: Fair market value on date established in Plan with respect to payment of fee or dividend F2 · derivative.exercise_date: Currently 100% vested F3 · derivative.expiration_date: The reporting director will receive common stock of the corporation on the first business day of the calendar year immediately following the year in which he or she ceases to be a director Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.